Purchase Order HHSN261201600573P

The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $18,000 firm fixed price purchase order to Caerus US 1 Inc. for SOFTWARE. The place of performance is New York, NY. The one year contract starts on July 26, 2023 and ends on July 25, 2024. No set aside designation or subcontractors were identified. The National Cancer Institute is a part of NIH focused on cancer research, so this contract is likely to deliver software products or...

This contract was awarded by the National Institutes of Health (NIH) National Cancer Institute to the Cancer Prevention Institute of California, a non-profit organization, to conduct a "Patterns of Care/Quality of Care Study: Diagnosis Year 2016" from July 31, 2017 to July 30, 2018. The contract, which has a firm fixed price of $159,811.00, is a delivery order that is not set aside for any particular business type. The study is part of the Surveillance, Epidemiology and End Results...

This $17,053.58 firm fixed price purchase order was awarded by the National Cancer Institute (NCI), a civilian agency, to an undisclosed prime contractor on September 11, 2024. The contract is for a service agreement with a period of performance through March 10, 2025. No set-aside designation is indicated. The contract award does not provide details about the specific products or services to be delivered, but as the NCI is the funding agency, the work is likely related to the institute's cancer...

The National Cancer Institute awarded a $144.7K firm fixed-price purchase order to the American College of Surgeons (ACS) on March 13, 2026, for a license to use the content of the American Joint Committee on Cancer (AJCC) cancer staging system, including application programming interface (API) access. The contract will be performed in Bethesda, Maryland, with an ultimate completion date of March 23, 2027. No set-aside designation was utilized for this procurement. As a non-profit organization...

The National Cancer Institute, a civilian agency within the U.S. Department of Health and Human Services, awarded a $14,225 firm fixed-price purchase order contract to N-Of-One, Inc., a self-certified small disadvantaged business, for laboratory testing services. This is the fifth prime federal contract awarded to N-Of-One by the National Cancer Institute between 2019 and 2020, with a total potential value across the awards of $89,700. The contract has an ultimate completion date of September...

This is a firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI) to the Cancer Prevention Institute of California. The contract, valued at $130,809.00, is for the Patterns of Care/Quality of Care Study for diagnosis year 2014 under the Surveillance, Epidemiology and End Results (SEER) program. The contract does not have a set-aside designation. The contract delivers products and services related to the SEER program, which is a major NCI program focused on...

The National Cancer Institute awarded a $27.3 million cost-plus-fixed-fee delivery order to Information Management Services, Inc. (IMS) on March 16, 2025, for services spanning data modeling, acquisition and management; data analytics including statistical programming and bioinformatics; and tool and software development. The base period runs from March 16, 2025, through March 15, 2026, with an ultimate completion date of January 15, 2030, and includes four option periods. The initial option...

This is a firm fixed-price delivery order awarded by the National Cancer Institute, a civilian agency, to the Cancer Prevention Institute of California. The $137,904 contract is for evaluating the feasibility of and potential biases in supplementing cancer registry data using external sources for the Surveillance, Epidemiology, and End Results (SEER) program. The period of performance is from September 18, 2015 to September 17, 2016. This contract award does not have a set-aside designation.

This is a Firm Fixed Price contract awarded by the National Cancer Institute (NCI), a civilian federal agency, to Pieces Technologies Inc., a small business, under the Small Business Innovation Research (SBIR) Phase II program. The contract, worth $1,999,994.00, is for the project titled "Passive and Active AI Screening for Social Determinants of Health and Interventions to Improve Outcomes in the Cancer Patient Population." The contract has a period of performance from September 16,...

This is a $24,996.00 firm fixed price purchase order awarded by the National Cancer Institute, a civilian agency, to Integrated Clinical Systems, Inc., a for-profit S-corporation, for the provision of software licensing, maintenance, and enhancement services. The contract is for the company's JReview software, which supports risk-based monitoring and analytics for clinical trials. Integrated Clinical Systems has provided similar services to the National Cancer Institute and the Food and Drug...